Lista de obras - Pieter M van Baal - Dominio Público Uruguay

A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

artículo científico publicado en 2018

Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data

artículo científico publicado en 2011

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

artículo científico publicado en 2007

Cost-effectiveness of lifestyle modification in diabetic patients

artículo científico publicado en 2009

DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact Assessments

artículo científico publicado en 2012

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

artículo científico publicado en 2011

Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life.

artículo científico publicado en 2014

Disability weights for comorbidity and their influence on health-adjusted life expectancy

artículo científico publicado en 2006

Disease prevention: saving lives or reducing health care costs?

artículo científico publicado en 2014

Does living longer in good health facilitate longer working lives? The relationship between disability and working lives

artículo científico publicado en 2015

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.

artículo científico publicado en 2008

Economic evaluation and the postponement of health care costs.

artículo científico publicado en 2011

Economics and public health: engaged to be happily married!

article

Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty

artículo científico publicado en 2011

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.

artículo científico publicado en 2006

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.

artículo científico publicado en 2011

Forecasting differences in life expectancy by education.

artículo científico publicado en 2016

Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patterns

artículo científico publicado en 2012

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

artículo científico publicado en 2019

Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis

artículo científico publicado en 2014

Future costs in economic evaluation. A comment on Lee.

artículo científico publicado en 2008

Future unrelated medical costs need to be considered in cost effectiveness analysis

artículo científico publicado en 2018

Health care input constraints and cost effectiveness analysis decision rules.

artículo científico publicado en 2018

Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level

artículo científico

Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective

article by Pieter M van Baal published 15 June 2012 in Heart

Increasing tobacco taxes: A cheap tool to increase public health

article

Indirect estimation of chronic disease excess mortality.

artículo científico publicado en 2010

Lifestyle intervention: from cost savings to value for money.

artículo científico publicado en 2009

Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.

artículo científico publicado en 2008

Mortality risk associated with disability: a population-based record linkage study

artículo científico publicado en 2011

PAID 1.0 in Practice

artículo científico publicado el 1 de junio de 2011

Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

artículo científico publicado en 2013

Probabilistic sensitivity analysis: be a Bayesian.

artículo científico publicado en 2009

Quality of life and time to death: have the health gains of preventive interventions been underestimated?

artículo científico publicado en 2014

Realistic Spatial Backcloth is not that Important in Agent Based Simulation Research

Should cost effectiveness analyses for NICE always consider future unrelated medical costs?

artículo científico publicado en 2017

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention

artículo científico publicado en 2011

The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA).

artículo científico publicado en 2012

The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries.

artículo científico publicado en 2015

The cost-effectiveness of increasing alcohol taxes: a modelling study.

artículo científico publicado en 2008

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action

artículo científico publicado en 2007

Time to death and the forecasting of macro-level health care expenditures: some further considerations

artículo científico publicado en 2012

Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach.

artículo científico publicado en 2012

To die with or from heart failure: a difference that counts

Trends in Dutch hospital spending by age and disease 1994-2010.

artículo científico publicado en 2014

Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.

artículo científico publicado en 2016

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio

artículo científico publicado en 2007

Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

artículo científico publicado en 2008

Weight change and incident diabetes: addressing an unresolved issue.

artículo científico publicado en 2010

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

artículo científico publicado en 2019

You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses

artículo científico publicado en 2016

Lista de obras de Pieter M van Baal

A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

Cost-effectiveness of lifestyle modification in diabetic patients

DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact Assessments

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life.

Disability weights for comorbidity and their influence on health-adjusted life expectancy

Disease prevention: saving lives or reducing health care costs?

Does living longer in good health facilitate longer working lives? The relationship between disability and working lives

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.

Economic evaluation and the postponement of health care costs.

Economics and public health: engaged to be happily married!

Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.

Forecasting differences in life expectancy by education.

Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patterns

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis

Future costs in economic evaluation. A comment on Lee.

Future unrelated medical costs need to be considered in cost effectiveness analysis

Health care input constraints and cost effectiveness analysis decision rules.

Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level

Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective

Increasing tobacco taxes: A cheap tool to increase public health

Indirect estimation of chronic disease excess mortality.

Lifestyle intervention: from cost savings to value for money.

Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.

Mortality risk associated with disability: a population-based record linkage study

PAID 1.0 in Practice

Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

Probabilistic sensitivity analysis: be a Bayesian.

Quality of life and time to death: have the health gains of preventive interventions been underestimated?

Realistic Spatial Backcloth is not that Important in Agent Based Simulation Research

Should cost effectiveness analyses for NICE always consider future unrelated medical costs?

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention

The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA).

The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries.

The cost-effectiveness of increasing alcohol taxes: a modelling study.

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action

Time to death and the forecasting of macro-level health care expenditures: some further considerations

Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach.

To die with or from heart failure: a difference that counts

Trends in Dutch hospital spending by age and disease 1994-2010.

Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio

Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Weight change and incident diabetes: addressing an unresolved issue.

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses